Objective: To evaluate the effect of luteal support with vaginal P suppositories in hMG- and hCG-induced cycles. Design: Between March 1988 and February 1989 patients did not receive luteal support, while between March 1989 and January 1990 P was given routinely in the luteal phase. Induction protocol and patient selection remained otherwise unchanged. Setting: Infertility clinic of a tertiary care hospital. Patients: Twenty-seven patients with hypogonadotropic amenorrhea (World Health Organization [WHO] group I) (11 women with luteal support, 16 women without) and 102 patients with euprolactinemic clomiphene citrate (CC)-resistant anovulation (WHO group II) (52 women with luteal support, 50 women without). Intervention: Vaginal P suppositories 200 mg/d in the luteal support group. Main Outcome Measures: Pregnancy rate (PR), pregnancy outcome. Results: The overall PR in 118 cycles with luteal support was 26.3% whereas 10.4% pregnancies were achieved in 115 cycles of the control group. The influence of luteal support was more pronounced in patients with CC-resistant anovulation (25.2% versus 6.9%) than in patients with hypogonadotropic amenorrhea (33.3% versus 21.4%, not significant). The abortion rate was not significantly changed. Conclusion: Luteal support with P increases the PR after hMG and hCG induction. The need for supplementary P seems to be related to the underlying cause of ovarian disturbance.
Hamilton, C. J. C. M., Jaroudi, K. A., & Sieck, U. V. (1993). The value of luteal support with progesterone in gonadotropin-induced cycles. Fertility and Sterility, 60(5), 786–790. https://doi.org/10.1016/S0015-0282(16)56277-3